A column in Forbes warns that services from companies like 23andMe may be today's equivalent of snake oil. 23andMe "is marketing an expensive bit of medical technology with little proof that it will do any good," the article says.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.
An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.
In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.
Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.